HIPAA-compliant · Same-day admissions available
Robin Campbell, LMFT, PHD Psychedelic substances are drawing new attention as researchers explore how these mind-altering drugs, also known as mind altering substances, can impact perception, consciousness, and mental health.
Maverick
Clinical Editorial Team
Psychedelic substances are drawing new attention as researchers explore how these mind-altering drugs, also known as mind altering substances, can impact perception, consciousness, and mental health. Clinical trials now examine their role in treating depression, post traumatic stress disorder, and other mental health disorders, while agencies like the Food and Drug Administration and Drug Enforcement Administration continue to evaluate safety concerns. As interest grows, questions remain about therapeutic use, potential benefits, and the risks connected to adverse effects, high doses, negative experiences, and adverse reactions. This blog looks at what emerging evidence suggests without assuming a clear outcome.
Psychedelics are substances that alter perception, mood, and thought in noticeable ways, and are classified as psychoactive substances that impact brain function and consciousness. They can create visual changes, alter sensory perceptions—including visual, auditory, and tactile experiences—and intensify emotional responses. These effects occur because psychedelics interact with serotonin receptors in the brain, which play a key role in mood and awareness. Many people explore them for curiosity, spiritual reasons, or self-reflection, but the experience can be unpredictable. For individuals with mental health concerns, these shifts can feel overwhelming and may raise safety risks.
Psychedelic drugs come in several types, each with unique effects and risks. Psychedelic drugs alter conscious perception and thinking processes, leading to unique experiences compared to other drug classes.
Psychedelics may help some people see patterns in their thoughts, feel more open, or process emotions in new ways. Some early studies show possible benefits for depression, PTSD, and substance use when care is structured and supervised. These possible benefits come with clear limits and many unknowns.
On the other side, psychedelics can trigger panic, paranoia, or confusion, and may cause adverse reactions such as psychological distress or other negative outcomes, especially without professional supervision. The presence of a trained therapist is crucial in guiding safe psychedelic experiences, providing emotional support, and helping individuals process their experiences effectively. They can push people with bipolar disorder, psychosis, or severe trauma into crisis. For individuals with a history of substance use disorder, psychedelic use may complicate recovery or mental health stability. At New Hope Healthcare Institute, we remind people that any “breakthrough” is not worth a serious mental health setback.
Psychedelics have roots in traditional spiritual and healing practices in many cultures. Indigenous groups used substances like peyote and ayahuasca in ceremonies with structure, meaning, and community guidance. Magic mushrooms containing psilocybin are also traditionally used in regions such as South America, where these fungi are commonly found and play a significant role in local practices. These settings helped contain the intensity of the experience. In the mid-20th century, researchers studied LSD and other psychedelics for depression, alcoholism, and end-of-life distress. Legal and safety concerns slowed this work for decades, but interest has grown again in recent years. Today, research returns under strict rules, while recreational use spreads with far less support or safety.
Recreational use happens in unsupervised settings like parties, festivals, or private homes. Doses are often unknown, and people may mix psychedelics with alcohol or other drugs. Alcohol abuse can complicate mental health conditions such as depression, PTSD, and addiction, increasing the risks and negative outcomes during psychedelic use. This raises the risk of panic, accidents, and mental health crises.
Clinical or research use follows clear screening, dosing, and monitoring guidelines. Licensed professionals check mental health history, explain risks, and stay present during and after the session. At New Hope Healthcare Institute, we focus on evidence-based care and do not promote unsupervised psychedelic use as a shortcut to healing.
Many psychedelics act on serotonin receptors in the brain, especially the 5-HT2A receptor. These substances primarily affect serotonin pathways, which underlies their main psychological effects. This changes how brain networks communicate and can loosen rigid thought patterns and sense of self. For some people this feels freeing; for others it feels like losing control. In the body, psychedelics can raise heart rate and blood pressure, change breathing, and cause nausea or sweating. People may also feel hot or cold, dizzy, or detached from their own body. These changes can be risky for those with heart conditions, high blood pressure, or other medical issues.
Further research is needed to fully establish the safety, efficacy, and best practices for psychedelic therapies. Psychoactive drugs may create mystical experiences for some people, but individuals with mental illness, mental disorders, or other psychiatric disorders still need evidence-based care such as antidepressant medication, since dissociative drugs work differently and carry unique risks.
A psychedelic-induced crisis may include extreme fear, panic, or a sense that reality is “broken.” The person may feel trapped in the experience, believe frightening ideas, or lose track of time and place. They might say they are “going crazy” or that nothing is real anymore. Other warning signs include aggressive behavior, self-harm talk, or attempts to escape a safe area. People with bipolar disorder or psychosis may show fast mood swings, bizarre thoughts, or severe confusion. If someone shows these signs, they need immediate medical and mental health support; in our programs at New Hope, we treat these emergencies as serious red flags, not spiritual “breakthroughs.”
Psychedelics can intensify emotions, causing feelings to rise quickly and with more force than usual. Some people report brief moments of insight or emotional release, while others experience fear, confusion, or a loss of control. These rapid shifts can disrupt emotional regulation and make it hard to stay steady during or after the experience.
For people with mental health issues, these effects can create added risks. Psychedelics may increase anxiety, worsen depression, or trigger intrusive thoughts in people with PTSD. They can also provoke manic episodes in individuals with bipolar disorder or bring on symptoms of psychosis in people with schizophrenia or a family history of it. Anyone managing these conditions should use extreme caution and seek guidance from a licensed professional before considering psychedelic use.
Psychedelics vary in how quickly they take effect and how long they last. LSD can take 30–60 minutes to start and may last 8–12 hours. Psilocybin often begins within 20–40 minutes and lasts 4–6 hours. DMT acts almost immediately and ends within 10–30 minutes. MDMA can take about 30–45 minutes to begin and lasts 3–6 hours. These timelines matter because long effects can intensify emotional strain and raise safety concerns for people with mental health issues.
In rare cases, some users may experience flashbacks or perception disturbances that persist for over a year after psychedelic use.
In psychiatry, psychedelics are studied in controlled environments to examine their effect on depression, PTSD, and anxiety. Specifically, psychedelic drugs such as psilocybin and LSD are the focus of these studies. These sessions involve screening, preparation, monitored dosing, and follow-up therapy. While early studies show possible benefits, the approach remains experimental. Programs like those at New Hope Healthcare Institute continue to rely on evidence-based treatments rather than unregulated psychedelic use.
Psychedelics do not usually cause physical addiction, but some people can still develop patterns of misuse. These substances can create powerful emotional experiences that some users try to repeat, leading to psychological dependence rather than physical cravings.
People may begin using psychedelics to escape stress, numb painful emotions, or chase a sense of insight. This pattern can disrupt daily life and increase mental health risks, especially for individuals already struggling with anxiety, depression, or trauma. When use becomes repetitive or begins replacing healthy coping skills, it may signal the need for professional support or treatment.
Psychedelic use is rising, especially among young adults and people seeking alternative mental health options. Many try substances like psilocybin or LSD at least once, often in social or festival settings. This growing curiosity increases the need for honest education about risks, especially for people in recovery.
For people in recovery, psychedelics can stir up the same drive for intense emotional or sensory experiences that fueled past substance use. This can lead to “substituting” psychedelics for alcohol, opioids, stimulants, or other drugs, creating a new cycle of escape rather than genuine healing. Once this pattern starts, binge use, risky decisions, and emotional instability can return quickly. These shifts can undo months of progress and place someone back into a vulnerable state where cravings and old habits resurface.
“Set” refers to someone’s mindset, expectations, mental health symptoms, and stress levels before using psychedelics. “Setting” refers to the environment, such as the people involved, the safety of the space, and the level of support available during the experience. If either one is unstable—like being around unsafe people, feeling anxious before the session, or using during conflict—the chance of panic, fear, or emotional overload rises sharply. Poor set and setting can turn a difficult moment into a full mental health crisis, especially for individuals with anxiety, trauma histories, or substance use disorders.
Many people believe that one strong psychedelic trip can “fix” depression, trauma, or addiction, but this belief skips the ongoing work required for real improvement. Coping skills, emotional stability, and healthy habits develop over time, not in a single experience. The quick-fix idea can lead people to stop therapy, abandon medication without medical guidance, or delay treatment programs that offer real support. At New Hope Healthcare Institute, we see how this mindset can set people back when they need steady care, not shortcuts.
People with bipolar disorder, schizophrenia, or a family history of psychosis face higher risk for severe reactions. Those with heart disease, uncontrolled high blood pressure, or serious medical issues may also be unsafe candidates. Anyone in early recovery, struggling with cravings, or using substances to cope should avoid psychedelics and seek structured support instead.
In clinical or research settings, trained professionals screen participants, review health history, and explain risks. During the session, they monitor vital signs, provide grounding, and help the person process difficult emotions. Afterward, integration sessions help connect insights to real-life changes, something that is missing completely in unsupervised or party use.
Psychedelics remain illegal under federal law, though some states and cities have decriminalized or reduced penalties for certain substances. Rules differ widely, which can confuse people about what is actually legal or safe. Even where laws soften, possession, distribution, or unlicensed “therapy” can still carry legal and financial consequences.
People in recovery often hear stories of “healing trips” on podcasts, social media, or from peers. This can create pressure to try psychedelics as a shortcut, especially when sobriety feels hard or slow. At New Hope Healthcare Institute, we talk openly about this curiosity and help clients weigh real risks against the promises they hear online.
Some mental health conditions make psychedelic use much riskier. Active psychosis, recent manic episodes, severe panic attacks, or ongoing suicidal thoughts can escalate quickly during a psychedelic experience. People with bipolar disorder, schizophrenia, or untreated trauma often react unpredictably and may enter a mental health crisis.
Substance use patterns are another warning sign. Someone who relies on alcohol, opioids, benzodiazepines, cocaine, or methamphetamine to cope may be more likely to misuse psychedelics or relapse. Hiding use, mixing substances, or seeking psychedelics as a way to “escape” stress shows a high-risk pattern.
Avoidance of treatment also matters. If someone ignores medical advice, refuses therapy, or downplays serious symptoms, psychedelics can add instability rather than insight. In these situations, structured mental health or addiction treatment should come first.
Some people hope psychedelics can speed up recovery, but they cannot replace the structure of proven addiction treatment. Psychedelics may create brief insight, yet they do not build coping skills, relapse prevention tools, or stable routines.
Ongoing therapy supports long-term change by addressing triggers, stress, and daily habits. Without this support, psychedelic experiences remain temporary and may even disrupt progress. Structured care, like the programs at New Hope Healthcare Institute, remains essential for lasting recovery.
Seek professional help if psychedelics cause lasting anxiety, panic, sleep problems, or confused thinking. Support is also needed if psychedelic use becomes a way to escape stress or replaces other substances. Anyone who feels unstable or unsafe after use should contact a mental health provider or a treatment program like New Hope Healthcare Institute.
Many insurance plans cover treatment for substance use disorders and related mental health concerns. Benefits often include therapy, outpatient services, and sometimes residential care. New Hope Healthcare Institute can help individuals verify their insurance and understand available options.
Psychedelic therapy continues to spark debate as studies and clinical trials, including research published in the New England Journal of Medicine, report both therapeutic effects and adverse events. Research suggests some classic psychedelics may offer sustained antidepressant effects for major depressive disorder, obsessive compulsive disorder, and severe depression, but more research is needed to understand long-term outcomes. Many psychedelic substances still carry risks such as bad trips, increased blood pressure, dangerous behavior, and other negative consequences, especially at very high doses or outside a clinical setting. As controlled substance regulations evolve and therapeutic use expands, individuals should rely on trained therapists, evidence-based care, and other treatments proven to support stability and safety over time.
At New Hope Healthcare, as an in-network provider we work with most insurance plans, such as:
If you or a loved one are struggling with mental health challenges or substance abuse, seeking treatment and emotional support is crucial. Consulting a doctor can provide the necessary support and guidance for your teen. Reach out to New Hope Healthcare today. Our team of compassionate professionals is here to support your journey towards lasting well-being. Effective medication management is a crucial part of the treatment process to ensure safety and success. Give us a call at 866-799-0806.
Visit SAMHSA for more information.
Psychedelics can raise risks for people with bipolar disorder, psychosis, or severe anxiety. They may trigger panic or unstable mood changes. A licensed professional should guide anyone considering use.
They rarely cause physical addiction, but some people develop psychological dependence. This happens when psychedelics become a way to avoid stress or emotions. Professional help is needed if use becomes repetitive or risky.
Some research shows possible benefits, but results vary. Psychedelics can also worsen symptoms or emotional stability. They should not replace structured mental health or addiction treatment.
Short-term effects can include altered perception, mood changes, and intense emotions. Some people experience fear, confusion, or panic. The experience can shift quickly, which makes it unpredictable.
Yes, psychedelics can intensify anxiety, depression, or trauma symptoms. They may also trigger episodes in people with bipolar disorder or psychosis. Anyone with a mental health history should use caution.
Some clinical studies explore psychedelics for depression and PTSD. These sessions use controlled settings and trained professionals. They remain experimental and are not a replacement for licensed treatment programs.
](https://www.nimh.nih.gov/health)
](https://nida.nih.gov/research-topics/hallucinogens)
](https://www.fda.gov/patients/clinical-trials-what-patients-need-know)
](https://www.dea.gov/drug-information/csa)
In This Article
Tags
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD Many parents are concerned about youth vaping, especially as vaping devices, e cigarettes, marijuana products, and other tobacco products become more common among high school students and other young people.
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD Alcohol use disorder affects people from all backgrounds and can range from risky drinking patterns to severe alcohol use disorder.
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD Teen vaping has become a growing concern for families across Knox County. Many parents worry about nicotine addiction, THC use, e cigarettes, and the long-term effects of tobacco and nicotine exposure on adolescents and young adults.
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD Opioid addiction can affect health, work, family, and daily life. Many patients who start with prescription pain relievers may develop substance use disorders that are hard to stop without support.
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD A benzo taper can be an important part of recovery for people who have become dependent on Xanax, Klonopin, Ativan, or other benzodiazepines.
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD Xylazine, a veterinary tranquilizer, is increasingly being found alongside fentanyl and other drugs in the illicit drug market, creating new challenges during the ongoing overdose crisis.
New Hope Health offers client-centered services. Reach out for a confidential consultation and see exactly how we'd apply these strategies to your facility.
